|
|
- Current emerging and investigational drugs for the treatment of chronic
hand eczema-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Julia Cheng, Paola Facheris, Benjamin Ungar, Emma Guttman-Yassky Pages: 1 - 11 Abstract: .
Citation: Expert Opinion on Investigational Drugs PubDate: 2022-06-17T08:37:52Z DOI: 10.1080/13543784.2022.2087059
- Invasive candidiasis: investigational drugs in the clinical development
pipeline and mechanisms of action-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Martin Hoenigl, Rosanne Sprute, Amir Arastehfar, John R. Perfect, Cornelia Lass-Flörl, Romuald Bellmann, Juergen Prattes, George R. Thompson, Nathan P. Wiederhold, Mohanad M. Al Obaidi, Birgit Willinger, Maiken C. Arendrup, Philipp Koehler, Matteo Oliverio, Matthias Egger, Ilan S. Schwartz, Oliver A. Cornely, Peter G. Pappas, Robert Krause Pages: 1 - 18 Abstract: .
Citation: Expert Opinion on Investigational Drugs PubDate: 2022-06-15T11:26:20Z DOI: 10.1080/13543784.2022.2086120
- Investigational therapeutics for the treatment of progressive supranuclear
palsy-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: David G Coughlin, Irene Litvan Pages: 1 - 11 Abstract: .
Citation: Expert Opinion on Investigational Drugs PubDate: 2022-06-13T08:55:27Z DOI: 10.1080/13543784.2022.2087179
- A phase 1b/2 study of PF-06747775 as monotherapy or in combination with
Palbociclib in patients with epidermal growth factor receptor mutant advanced non-small cell lung cancer Open Access Article-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Byoung Chul Cho, Sarah B Goldberg, Dong-Wan Kim, Mark A Socinski, Timothy F Burns, Zarnie Lwin, Nuzhat Pathan, Wei Dong Ma, Joanna C Masters, Nandini Cossons, Keith Wilner, Makoto Nishio, Hatim Husain Pages: 1 - 11 Abstract: .
Citation: Expert Opinion on Investigational Drugs PubDate: 2022-06-03T03:48:05Z DOI: 10.1080/13543784.2022.2075341
- Experimental drug treatments for hepatocellular carcinoma: clinical trial
failures 2015 to 2021-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Zachary J. Brown, D. Brock Hewitt, Timothy M. Pawlik Pages: 1 - 14 Abstract: .
Citation: Expert Opinion on Investigational Drugs PubDate: 2022-05-26T07:42:20Z DOI: 10.1080/13543784.2022.2079491
- Pharmacokinetics, safety, and tolerability of TQC3564, a novel CRTh2
receptor antagonist: report of the first-in-human single- and multiple-dose escalation trials in healthy Chinese subjects-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Xiaojiao Li, Qianqian Li, Tianliang Ji, Hong Zhang, Jingrui Liu, Min Wu, Hong Chen, Jinfeng Lou, Chengjiao Liu, Zhongnan Xu, Yanhua Ding Pages: 1 - 8 Abstract: .
Citation: Expert Opinion on Investigational Drugs PubDate: 2022-05-18T07:19:29Z DOI: 10.1080/13543784.2022.2078192
- Adenosine pathway inhibitors: novel investigational agents for the
treatment of metastatic breast cancer-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Alessandro Rizzo, Raffaella Massafra, Annarita Fanizzi, Lucia Rinaldi, Antonio Cusmai, Agnese Latorre, Gian Maria Zaccaria, Maria Ronchi, Michele Telegrafo, Gennaro Gadaleta-Caldarola, Francesco Giotta, Vito Lorusso, Gennaro Palmiotti Pages: 1 - 7 Abstract: .
Citation: Expert Opinion on Investigational Drugs PubDate: 2022-05-18T07:19:09Z DOI: 10.1080/13543784.2022.2078191
- Investigational drugs for ischemic stroke: what’s in the clinical
development pipeline for acute phase and prevention'-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Maria Giulia Mosconi, Maurizio Paciaroni, Walter Ageno Pages: 1 - 23 Abstract: .
Citation: Expert Opinion on Investigational Drugs PubDate: 2022-05-13T07:15:39Z DOI: 10.1080/13543784.2022.2072725
- Investigational drugs for immune thrombocytopenia
-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Drew Provan, Adrian C Newland Pages: 1 - 13 Abstract: .
Citation: Expert Opinion on Investigational Drugs PubDate: 2022-05-11T07:19:46Z DOI: 10.1080/13543784.2022.2075340
- Novel immunotherapy combinations in clinical trials for hepatocellular
carcinoma: will they shape the future treatment landscape' Open Access Article-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Claudia Angela Maria Fulgenzi, Antonio D’Alessio, Olabisi Ogunbiyi, Coskun O. Demirtas, Alessandra Gennari, Alessio Cortellini, Rohini Sharma, David James Pinato Pages: 1 - 11 Abstract: .
Citation: Expert Opinion on Investigational Drugs PubDate: 2022-05-06T12:06:51Z DOI: 10.1080/13543784.2022.2072726
- PARP inhibitors as single agents and in combination therapy: the most
promising treatment strategies in clinical trials for BRCA-mutant ovarian and triple-negative breast cancers-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Linjie Luo, Khandan Keyomarsi Pages: 1 - 25 Abstract: .
Citation: Expert Opinion on Investigational Drugs PubDate: 2022-05-03T03:14:33Z DOI: 10.1080/13543784.2022.2067527
- Clinical development of antibody-drug conjugates in triple negative breast
cancer: can we jump higher'-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Dimitrios Zardavas Pages: 1 - 12 Abstract: .
Citation: Expert Opinion on Investigational Drugs PubDate: 2022-05-02T03:48:59Z DOI: 10.1080/13543784.2022.2070064
- A randomized, open-label, single-dose, two-cycle crossover study to
evaluate the bioequivalence and safety of lenvatinib and Lenvima® in Chinese healthy subjects-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Zhongnan Xu, Yanli Wang, Guangwen Liu, Jiahui Chen, Wanhua Wang, Yang Cheng, Qing Ren, Yingzi Cui, Wei Yang, Zhengzhi Liu, Xuesong Chen, Jinling Xue, Tianying Chang, Xinyao Qu, Shuang Yu, Yannan Zhou, Kaibo Xu, Zhengjie Su, Qiaohuan Deng, Yicheng Zhao, Haimiao Yang Pages: 1 - 10 Abstract: .
Citation: Expert Opinion on Investigational Drugs PubDate: 2022-04-19T11:19:30Z DOI: 10.1080/13543784.2022.2067528
- CAR-T cell therapy for triple-negative breast cancer and other solid
tumors: preclinical and clinical progress-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Chiara Corti, Konstantinos Venetis, Elham Sajjadi, Lorenzo Zattoni, Giuseppe Curigliano, Nicola Fusco Pages: 1 - 13 Abstract: .
Citation: Expert Opinion on Investigational Drugs PubDate: 2022-03-24T08:38:36Z DOI: 10.1080/13543784.2022.2054326
- Progress and pitfalls in the use of immunotherapy for patients with triple
negative breast cancer-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Elisa Agostinetto, Agnese Losurdo, Guilherme Nader-Marta, Armando Santoro, Kevin Punie, Romualdo Barroso, Lazar Popovic, Cinzia Solinas, Marleen Kok, Evandro de Azambuja, Matteo Lambertini Pages: 1 - 25 Abstract: .
Citation: Expert Opinion on Investigational Drugs PubDate: 2022-03-09T04:10:28Z DOI: 10.1080/13543784.2022.2049232
- Ladiratuzumab vedotin for metastatic triple negative cancer: preliminary
results, key challenges, and clinical potential-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Alessandro Rizzo, Antonio Cusmai, Silvana Acquafredda, Lucia Rinaldi, Gennaro Palmiotti Pages: 1 - 4 Abstract: .
Citation: Expert Opinion on Investigational Drugs PubDate: 2022-02-18T02:10:18Z DOI: 10.1080/13543784.2022.2042252
- A randomized, adaptive design, double-blind, 3-arm, parallel study
assessing the pharmacokinetics and safety of AVT02, a high-concentration (100 mg/mL) Adalimumab biosimilar, in healthy adult subjects (ALVOPAD FIRST) Open Access Article-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Christopher Wynne, Christian Schwabe, Charlotte Lemech, Heimo Stroissnig, Roshan Dias, Joanna Sobierska, Eric Guenzi, Hendrik Otto, Abid Sattar, Richard Kay, Halimu N. Haliduola, Fausto Berti Pages: 1 - 12 Abstract: .
Citation: Expert Opinion on Investigational Drugs PubDate: 2022-02-10T02:25:59Z DOI: 10.1080/13543784.2022.2035359
|